Results

Total Results: 904 records

Showing results for "author year description".

101. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - Methods The section contains a summary of the project methods; a full description is available as … A-3 The following data were abstracted: • Study identifier (author) and publication year • Study … No. 24-EHC011 March 2024 C-2 Author, Year Related Studies Trial ID Location Setting … No. 24-EHC011 March 2024 C-3 Author, Year Related Studies Trial ID Location Setting … No. 24-EHC011 March 2024 C-4 Author, Year Related Studies Trial ID Location Setting

102. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - The first is a paper that was presented in Germany the same day as ref 6, but published the next year … with the diagnostic meta- analysis estimates for sensitivity, specificity, likelihood ratios and a description … The tables in the appendix follow a standard EPC format (search strategy, excluded studies, description … I did not find the an explicit description of the intended audience No other concerns.

103. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - Characteristics” for Key Question 1, we report that “the median age of patients was between 60 and 70 year … Peer Reviewer#1 Introduction The description needs to be clarified regarding the clinical indications … Peer Reviewer#1 Methods There is no description of whether or not the authors included grey literature … An explanation of how pain was evaluated is included in each study description. … than compression alone, especially for ulcers that had failed therapy and were present for over 1 year

104. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
     August 01, 2020 - Published literature on care settings, services, and logistical support Topic Author, Year, Study … Published literature on extended-release medication based treatments Author, Year Study Design … KQ3: Not reported Fair B-23 Author, Year Study Design Country Funder Number of … Quality ratings for contingency management Author, Year Randomization Allocation Concealment … Quality ratings for psychosocial Author, Year Randomization Allocation Concealment Groups

105. Disposition of Comments for CER 175 Total Worker Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
     May 31, 2016 - Unfortunately, companies don't care about studies of less than one year. … that the duration of included studies is a limitation; very few studies measured outcomes beyond one year … We agree that a descriptive paper focused on the pre-post interventions (including a description of … Seems like a missed opportunity for those 5-year trials. … Distinguishing between these possibilities from a program description in the literature may be challenging

106. Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
     September 10, 2014 - Introduction Same point again about the “large proportion” of women undergoing biopsy over a 10 year … Executive Summary Actually, the 10 year false positive biopsy rate is 7% for annual screening and … a more detailed description in the Main Report text. … a more detailed description in the Main Report text. … If one year f/u results in the loss of many studies this could be relaxed; but including studies with

107. Monitoring-Programs-Rapid-Research-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
     October 08, 2025 - Detailed Information for Contextual Questions 1, 2, and 3 Studies Author, Year Publication Description … Country Setting(s) Purpose Targeted Supply/Disruption Type of Monitoring System Description of Monitoring

108. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

109. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

110. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
     February 24, 2016 - Co-Author Dr. Fitzgerald may be a resource for this. … We have replaced the word "accepted" with "validated," although we are not sure this description is … Space is limited in the abstract and didn't permit a full description. … The AHRQ systematic review report format specifies we begin the Results section with a description … We have clarified it in the description, which we moved down in that section.

111. Noninvasive Diagnostic Techniques for the Detection of Skin Cancers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
     December 01, 2014 - We also extracted data on the citation (first author name, journal, and year of publication), condition … year 1999), and MoleMax (Derma Medical Systems; decision year 1999). … RCTs identified in the present technical brief First Author UI Country year Study Objective … RCTs identified in the present technical brief (continued) First Author UI Country year Study … RCTs identified in the present technical brief (continued) First Author UI Country year Study

112. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - Perhaps a brief description of the methodology to quantitate omega-3 levels for the included studies … have added it to the description of the findings of this study. … Author name “van Goor”-this study is presented in the tables twice, pg 132 & pg 133-134 Pg 170 line … We have made every effort to be transparent in our description of our methods and decisions. … Customarily, update searches commence with the publication year one year prior to the latest search

113. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - This should be done using Corporate Author and keyword searches. … The Corporate Author search alone is not reliable. … Three-year follow-up of the tube versus trabeculectomy study. … Also, as the author points out, there is no formal economic analysis comparing trabeculectomy, laser … A description of the studies included precedes this paragraph, but there is no description or metaanalysis

114. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Clearly newborns barely make immunoglobulin whereas 18 year olds have adult levels. … None of the studies looked specifically at children with joint swelling; we added this to the description … We have reworded the outcome description for KQ5. … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup

115. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
     October 15, 2024 - cycle length, with elevated but variable follicle-stimulating hormone (FSH, >25 IU/L), and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … ti,bt,kf. 37578 29 Structure # Searches Results Description 56 ("use" adj3 (medication … or therap*)).ti,bt,ab,kf. 155871 30 Structure # Searches Results Description 59 (

116. Dispostion of Comments Report for Child and Adolescent Exposure to Trauma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
     February 11, 2013 - We have added some description about the main findings of the child maltreatment complementary report … subject to terrorist attacks over a number of years prior to the intervention or to the Tsunami over a year … N/A Peer Reviewer #2 Methods Concise description of evidence grading is given N/A TEP #5 Methods … authors explain that differentiation of theoretical orientation is limited because in many studies, the description … Excluded for “wrong publication type” (e.g., Appendix C) – I may have missed it, but I didn’t see description

117. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
     August 16, 2016 - We have clarified the description of grading strength of evidence. … The description has been modified. TEP Reviewer #5 Introduction P 3. … We also added to the description of the RCTs and the discussion. … The description has been modified. … We have added this description to CORAL and included the limitation in that section of the Discussion

118. Future Research Needs for Childhood Obesity Prevention Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/child-obesity-future_research.pdf
     March 31, 2010 - The findings and conclusions in this document are those of the author(s), who are responsible for its … The stakeholders consistently favored prioritizing school-aged children (6 to 12 year-olds); they also … data collection date for primary outcome measure) Purpose: To evaluate the effects of a three- year … with a standard primary care-only intervention among 500 low income ethnic minority two to four year … Purpose: The purpose of this project is to reduce health disparities in obesity risk among 8-10 year

119. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - We added a description of myxedema coma Source: http://www.effectivehealthcare.ahrq.gov/index.cfm … UPdate...nearly 1 year old). … Introduction p. 14, line 43--on the third review, state number and type of studies We have added this description … As noted above, these two studies are problematic and there is no evidence to support a 1-2 year observation … We removed the “1-2 year” from the sentence Peer Reviewer #6 Results Table 10AB is great, except

120. Disposition of Comments for Strategies To Prevent Weight Gain Among Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
     March 25, 2013 - We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc. … Peer Reviewer 1 Results Table 14 – Primary Aim is missing as is description of “Group 1” Study … Commentator & Affiliation Section Comment Response Peer Reviewer 1 Results Table 15 – based on the description … We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc. … We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc.